Technologies Enabling Resilient Pharmaceutical Supply Chains

Description

AI-enabled Technologies are Transforming the Pharmaceutical Supply Chain Network

This study aims to review emerging, transformative technology solutions that redesign pharmaceutical supply chain processes and introduce increased resilience, transparency, and responsiveness into the model.

The study answers the following questions: What are some new challenges big pharma's supply chains must address today? How can emerging technologies help lead the way in transparency and resilience? How do different technological solutions allow connectivity and communication among important pharmaceutical supply chain stakeholders? Given the recent global economic shocks, what new technology application strategies can pharmaceutical companies deploy to make their supply chains more responsive and efficient? How can managers implement supplier synergies with technology companies and pharmaceutical companies benefit from formulating a more solid and integrated model for the pharmaceutical industry's supply chain? How do the funding, technical readiness, and strategic collaborations of key companies in this field influence the development and potential success of the pharmaceutical supply chain?

Product Code: DB13

Strategic Imperatives

Why Is It Increasingly Difficult to Grow?
The Strategic Imperative 8™
The Impact of the Top 3 Strategic Imperatives on the Technologies Enabling Resilient Pharmaceutical Supply Chains
Growth Opportunities Fuel the Growth Pipeline Engine™
Research Methodology

Growth Opportunity Analysis

Scope of Analysis
Introduction
Segmentation

Growth Generator

Growth Drivers
Growth Restraints

Harnessing Technology: A New Era in Pharmaceutical Supply Chain Management

Manufacturers to Wholesalers
Wholesalers to Pharmacies
Pharmacies to Patients

Emerging Innovation Landscape for the Pharmaceutical Supply Chain

Key Pharmaceutical Supply Chain Participants

Impact of Stakeholders on Pharmaceutical Supply Chain Efficiency

Funding Analysis
Key Partnerships and Acquisitions, 2021-2024

Ensuring Access and Safety in Drug Distribution

Manufacturers to Wholesalers-Outlook
Wholesalers to Pharmacies-Outlook
Pharmacies to Patients-Outlook

Growth Opportunity Universe in the Pharmaceutical Supply Chain

Growth Opportunity 1: IoT-enabled Tracking and Monitoring
Growth Opportunity 2: Blockchain for Enhanced Transparency and Traceability
Growth Opportunity 3: Data Analytics and AI-driven Decision-making

Next Steps

Benefits and Impacts of Growth Opportunities
Next Steps
Legal Disclaimer